# A Randomized, Double-blind, Placebo-controlled Study on the Efficacy and Safety of CVT-E002 in the Treatment of Upper Respiratory Tract Infections in a Pediatric (3-11 Years) Population

> **NCT00965822** · PHASE2 · COMPLETED · sponsor: **Afexa Life Sciences Inc** · enrollment: 293 (actual)

## Conditions studied

- Upper Respiratory Tract Infections

## Interventions

- **OTHER:** North American ginseng
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00965822
- **Lead sponsor:** Afexa Life Sciences Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2012-04
- **Final completion:** 2012-04
- **Target enrollment:** 293 (ACTUAL)
- **Last updated:** 2012-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00965822

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00965822, "A Randomized, Double-blind, Placebo-controlled Study on the Efficacy and Safety of CVT-E002 in the Treatment of Upper Respiratory Tract Infections in a Pediatric (3-11 Years) Population". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00965822. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*